Orgenesis Inc. (ORGS) Social Stream
ORGENESIS INC (ORGS) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ORGS.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued March 22, 2023
The Trend in the Analyst Price Target
ORGS's average price target has moved down $3 over the prior 42 months.
500 - Internal server error
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
ORGS Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ORGS as an investment opportunity.
- In terms of how ORGENESIS INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than nearly none of that group.
- ORGS has a lower variance in analysts' estimates than almost 100% of all US stocks.
- In the context of Healthcare stocks, ORGENESIS INC's upside potential (average analyst target price relative to current price) is greater than 182.81% of them.
- In terms of how ORGENESIS INC fares relative to Healthcare stocks, note that its average analyst price target is higher than 24.07% of that group.
Is ORGS a Buy, Hold or Sell? See the POWR Ratings now!